The Peptide Field
Menu

Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Narrow the list

Filters

Showing 121–140 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

121
FDA reviewU.S. Food and Drug Administration · 2024Checked 2026-07-23

FDA briefing document for AOD-9604-related bulk drug substances

Reviews using this sourceAOD-9604
Open source
122
RegulatoryU.S. Food and Drug Administration · 2021Checked 2026-07-23

Sterile compounded AOD-9604 recall for lack of sterility assurance

Reviews using this sourceAOD-9604
Open source
123
FDA reviewU.S. Food and Drug Administration · 2026Checked 2026-07-23

FDA briefing document for epitalon-related bulk drug substances

Reviews using this sourceEpitalon
Open source
124
PreclinicalPubMed · Biogerontology · 2025Checked 2026-07-23

Epitalon and telomere length in human cell lines

Reviews using this sourceEpitalon
Open source
125
RegulatoryU.S. Food and Drug Administration · 2026Checked 2026-07-23

July 2026 Pharmacy Compounding Advisory Committee meeting

Reviews using this sourceEpitalonSemaxDSIP
Open source
126
Drug labelU.S. Food and Drug Administration · 2020Checked 2026-07-23

VYLEESI (bremelanotide) prescribing information

Reviews using this sourceBremelanotide
Open source
127
Randomized trialPubMed · Obstetrics & Gynecology · 2019Checked 2026-07-23

Bremelanotide for HSDD: two randomized phase 3 trials

Reviews using this sourceBremelanotide
Open source
128
FDA reviewU.S. Food and Drug Administration · 2019Checked 2026-07-23

Vyleesi multidisciplinary review

Reviews using this sourceBremelanotide
Open source
129
Drug labelU.S. Food and Drug Administration · 2024Checked 2026-07-23

SCENESSE (afamelanotide) prescribing information

Reviews using this sourceAfamelanotide
Open source
130
Randomized trialPubMed · New England Journal of Medicine · 2015Checked 2026-07-23

Afamelanotide for erythropoietic protoporphyria

Reviews using this sourceAfamelanotide
Open source
131
RegulatoryU.S. Food and Drug Administration · 2019Checked 2026-07-23

Afamelanotide orphan drug designation and approval

Reviews using this sourceAfamelanotide
Open source
132
Drug labelU.S. Food and Drug Administration · 2024Checked 2026-07-23

FORTEO (teriparatide) prescribing information

Reviews using this sourceTeriparatide
Open source
133
Randomized trialPubMed · New England Journal of Medicine · 2001Checked 2026-07-23

Parathyroid hormone for postmenopausal osteoporosis

Reviews using this sourceTeriparatide
Open source
134
Randomized trialPubMed · Clinical Orthopaedics and Related Research · 2016Checked 2026-07-23

Teriparatide and femoral-neck fracture healing

Reviews using this sourceTeriparatide
Open source
135
Drug labelU.S. Food and Drug Administration · 2025Checked 2026-07-23

TYMLOS (abaloparatide) prescribing information

Reviews using this sourceAbaloparatide
Open source
136
Randomized trialPubMed · JAMA · 2016Checked 2026-07-23

Abaloparatide vs placebo on new vertebral fractures: ACTIVE

Reviews using this sourceAbaloparatide
Open source
137
Drug labelU.S. Food and Drug Administration · 2025Checked 2026-07-23

GATTEX (teduglutide) prescribing information

Reviews using this sourceTeduglutide
Open source
138
Randomized trialPubMed · Gastroenterology · 2012Checked 2026-07-23

Teduglutide reduces parenteral support in short bowel syndrome

Reviews using this sourceTeduglutide
Open source
139
RegulatoryU.S. Food and Drug Administration · 2019Checked 2026-07-23

Teduglutide orphan drug designation and approval

Reviews using this sourceTeduglutide
Open source
140
Human pilotPubMed · Life Sciences · 1996Checked 2026-07-31

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide, in a pilot phase-I clinical study

Reviews using this sourceMelanotan II
Open source

About this list

How this list works

This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.